Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New RNA Research Kits Save Time, Reduce Variability

By LabMedica International staff writers
Posted on 03 Jun 2010
Two assay kits for RNA research are among several new products recently made available to molecular biologists and genome researchers.

Two assay systems recently released for marketing by Qiagen (Hilden, Germany) focus on RNA research. More...
The first is called "FlexiTube siRNA Premix.” In this product siRNA for the gene of interest and a highly efficient transfection reagent are already premixed and provided in a single tube.

FlexiTube siRNA Premix includes a specialized buffer that increases the stability of siRNA-reagent complexes. The ratio of reagent to siRNA in FlexiTube siRNA Premix is preoptimized to provide the highest transfection efficiency and gene knockdown. FlexiTube siRNA Premix is ready-to-use for cell transfection. The user simply adds the reagents to cells and incubates. This saves a significant amount of time and labor compared to a typical transfection experiment in which siRNA is diluted, mixed with transfection reagent, and then incubated to allow siRNA-reagent complex formation prior to adding the complexes to the cells and incubating.

With FlexiTube siRNA Premix, RNAi experiments get off to a faster start, as there is no need to optimize siRNA to reagent ratio. Tedious optimization experiments involving multiple transfections are minimized or eliminated, as FlexiTube siRNA Premix provides siRNA and reagent premixed at an optimal ratio. Multiple transfections can be performed from a single FlexiTube siRNA Premix, which reduces variability, enabling consistency across experiments and more reliable results.

The second line of products for RNA research is "miScript Target Protectors.” These are innovative tools that provide valuable insights into the roles of miRNAs in regulation of individual genes. A miScript Target Protector is designed to protect the miRNA-binding site of a specific target gene. After transfection, the miScript Target Protector binds to the miRNA-binding site, blocking miRNA access to the site and preventing gene downregulation by a specific miRNA.

miScript Target Protector transfection is followed by phenotype or gene expression analysis. Increased target-gene expression, a change in signaling patterns, or an altered phenotype, can all provide evidence that the miRNA and target under study are involved in the pathway or phenotype of interest. The role of miRNAs in various pathways can be studied by examination of specific phenotypes after transfection of different miScript Target Protectors.

Information about these and other genomic research tools is easily accessed through the "GeneGlobe” portal located at Qiagen's website.

Related Links:
Qiagen



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automatic Hematology Analyzer
DH-800 Series
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.